Eric P. Rahrmann, Ph.D.
Affiliations: | 2011 | Molecular, Cellular, Developmental Biology and Genetics | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
Genetics, Oncology, Human DevelopmentGoogle:
"Eric Rahrmann"Parents
Sign in to add mentorDavid A. Largaespada | grad student | 2011 | UMN | |
(Identification of novel genes involved in prostate and Schwann cell malignancies utilizing a Sleeping Beauty transposon somatic cell mutagenesis screen.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Rahrmann EP, Shorthouse D, Jassim A, et al. (2022) The NALCN channel regulates metastasis and nonmalignant cell dissemination. Nature Genetics |
Watson AL, Keller BJ, Williams KA, et al. (2020) Correction: Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. Oncotarget. 11: 3618-3620 |
Smeester BA, Draper GM, Slipek NJ, et al. (2020) Implication of ZNF217 in accelerating tumor development and therapeutically targeting ZNF217-induced PI3K-AKT signaling for the treatment of metastatic osteosarcoma. Molecular Cancer Therapeutics |
Smeester BA, Slipek NJ, Pomeroy EJ, et al. (2020) PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma. Bone. 115353 |
Smeester BA, Slipek NJ, Pomeroy EJ, et al. (2019) SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis. Oncogene |
Beckmann PJ, Larson JD, Larsson AT, et al. (2019) Sleeping Beauty insertional mutagenesis reveals important genetic drivers of central nervous system embryonal tumors. Cancer Research |
Rahrmann EP, Wolf NK, Otto GM, et al. (2018) Sleeping Beauty Screen Identifies RREB1 and Other Genetic Drivers in Human B-cell Lymphoma. Molecular Cancer Research : McR |
Moriarity BS, Otto GM, Rahrmann EP, et al. (2015) A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis. Nature Genetics. 47: 615-24 |
Das P, Jackson P, Moriarity B, et al. (2015) PTPS-02FOXR2: AN ONCOGENE IN MEDULLOBLASTOMA Neuro-Oncology. 17: v179.2-v179 |
Rathe SK, Moriarity BS, Stoltenberg CB, et al. (2014) Using RNA-seq and targeted nucleases to identify mechanisms of drug resistance in acute myeloid leukemia. Scientific Reports. 4: 6048 |